The ribG gene at the 5 end of the riboflavin operon of Bacillus subtilis and a reading frame at 442 kb on the Escherichia coli chromosome (subsequently designated ribD) show similarity with deoxycytidylate deaminase and with the RIB7 gene of Saccharomyces cerevisiae. The ribG gene of B. subtilis and the ribD gene of E. coli were expressed in recombinant E. coli strains and were shown to code for bifunctional proteins catalyzing the second and third steps in the biosynthesis of riboflavin, i.e., the deamination of 2,5-diamino-6-ribosylamino-4(3H)-pyrimidinone 5-phosphate (deaminase) and the subsequent reduction of the ribosyl side chain (reductase). The recombinant proteins specified by the ribD gene of E. coli and the ribG gene of B. subtilis were purified to homogeneity. NADH as well as NADPH can be used as a cosubstrate for the reductase of both microorganisms under study. Expression of the N-terminal or C-terminal part of the RibG protein yielded proteins with deaminase or reductase activity, respectively; however, the truncated proteins were rather unstable.
The initial steps in the pathway of riboflavin biosynthesis are shown in Fig. 1 . Briefly, the first committed step is catalyzed by GTP cyclohydrolase II and involves the release of formate and of pyrophosphate from GTP (compound 1). The product, 2,5-diamino-6-ribosylamino-4(3H)-pyrimidinone 5Ј-phosphate (compound 2), is converted to 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione 5Ј-phosphate (compound 5) in two steps involving the reduction of the ribosyl side chain and the deamination of the pyrimidine ring. Early studies with the yeast Saccharomyces cerevisiae showed that the reduction of the side chain precedes the deamination of the ring, and 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5Ј-phosphate (compound 4) was proposed as an intermediate (18) . This sequence of reactions was later confirmed by enzymatic in vitro studies with Ashbya gossypii and S. cerevisiae (10, 11, 17) .
On the other hand, enzyme studies with Escherichia coli indicated that the deamination reaction precedes the reduction of the ribosyl side chain. An enzyme catalyzing the deamination of compound 2 under formation of 5-amino-6-ribosylamino-2,4(1H,3H)-pyrimidinedione 5Ј-phosphate (compound 3) was purified 200-fold from cell extract of E. coli (6) . It did not accept the dephosphorylated form of compound 2 as substrate. An enzyme catalyzing the reduction of compound 3 conducive to formation of compound 5 was also purified 200-fold from E. coli extract. This enzyme required NADPH as cofactor and was unable to utilize the dephosphorylated form of compound 3 as substrate.
In Bacillus subtilis, all enzymes of riboflavin biosynthesis are specified by an operon located at a position of 210Њ on the chromosome (7) . The rib operon has been sequenced independently by two research groups and was shown to contain five open reading frames, designated ribG, ribB, ribA, ribH, and ribT (15, 20) . The gene ribB codes for riboflavin synthase (22) , ribH codes for lumazine synthase (12) , and ribA codes for a bifunctional protein with GTP cyclohydrolase II and 3,4-dihydroxy-2-butanone 4-phosphate synthase activity (21a).
Perkins et al. (20) noted that the ribG gene located at the 5Ј end of the operon shows some similarity to deoxycytidylate deaminases from bacteriophage T2 and S. cerevisiae (13, 14) and proposed that the ribG gene could code for the deaminase converting compound 2 to compound 3. They further proposed that the gene ribT could code for the reductase catalyzing the conversion of 5-amino-6-ribosylamino-2,4(1H,3H)-pyrimidinedione 5Ј-phosphate (compound 3) to 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione 5Ј-phosphate (compound 5) (20) . The present paper shows that the ribG gene of B. subtilis and the homologous ribD gene of E. coli (24) code for a bifunctional deaminase-reductase of the riboflavin pathway.
MATERIALS AND METHODS

Materials.
Primers were synthesized by MWG-Biotech (Ebersberg, Germany). The Geneclean II kit was from Bio 101 (La Jolla, Calif.), and the pBluescript II SK Ϫ vector was obtained from Stratagene. The plasmids pRF2, pNCO113, and p602/22 were a gift of A. van Loon, Hoffmann-La Roche AG, Basel, Switzerland. 6,7-Dimethyl-8-ribityllumazine (1), 6,7-dimethyl-8-ribityllumazine 5Ј-phosphate (8), 6,7-dimethyllumazine (2), and 6,7-dimethylpterin (2) were prepared by published procedures. QAE cellulose QA92 was obtained from Whatman. Butyl Sepharose 4 FF and Superdex 200 were obtained from Pharmacia Biotech. NADH, NADPH, and glucose 6-phosphate were obtained from Boehringer, Mannheim, Germany.
GenBank-EMBL accession numbers. The ribG gene of B. subtilis (accession no. X51510) has been sequenced by Mironov et al. (15) and by Perkins et al. (20) . The ribD gene of E. coli was reported as an open reading frame with homology to ribG by Taura et al. (24) under accession numbers X64395 and S47077.
Proteins. Restriction enzymes were obtained from New England Biolabs and Pharmacia Biotech. T4 DNA ligase was obtained from Gibco-BRL, and Taq DNA polymerase was obtained from Eurogentec. Alkaline phosphatase and DNase were obtained from Boehringer, Mannheim, Germany. Lysozyme and glucose 6-phosphate dehydrogenase were obtained from Sigma. GTP cyclohydrolase II of E. coli was isolated from a recombinant E. coli strain (21) .
Bacterial strains and plasmids. Bacterial strains and plasmids used in this study are summarized in Table 1 . The plasmids pNCO113 and p602/22 (shuttle vector for E. coli and B. subtilis) (Fig. 2) were kindly provided by A. van Loon, Hoffmann-La Roche AG. The shuttle vector p602/-CAT was constructed by removal of a part of the chloroamphenicol acetyltransferase gene from the expression plasmid p602/22 (16) . The kanamycin resistance gene is retained in this plasmid.
Culture media. E. coli cells were grown in Luria-Bertani (LB) medium. Riboflavin-deficient mutants of E. coli require very high concentrations of riboflavin for growth. The vitamin was added to culture media at a concentration of 400 mg/liter and was dissolved by autoclaving at 121ЊC for 20 min.
Enzyme assays.
A method for assaying the deaminase and reductase of E. coli based on 14 C-labeled GTP has been described by Burrows and Brown (6) . A different assay method was developed in the course of our studies.
Briefly, substrate 2 for pyrimidine deaminase (Fig. 3) was obtained from GTP with recombinant GTP cyclohydrolase II of E. coli. In order to assay the deaminase activity, substrate 2 was incubated with the bifunctional deaminase-reductase in the absence of reduced pyrimidine nucleotide cofactor. Enzyme product 3 was converted to 6,7-dimethyllumazine (compound 8) by reaction with diacetyl. Remaining substrate 2 was converted to 6,7-dimethylpterin (compound 7) by this procedure.
The substrate for reductase is obtained by treatment of GTP with GTP cyclohydrolase II and recombinant RibD protein of E. coli, yielding compound 3 ( Fig.  3) , which was separated from protein by ultrafiltration. NADPH used as cosubstrate for reductase was regenerated in situ by glucose 6-phosphate dehydrogenase. The product of the reductase, compound 5, was converted to 6,7-dimethyl-8-ribityllumazine 5Ј-phosphate (compound 9) by treatment with diacetyl, and remaining substrate was converted to dimethyllumazine (compound 8). Products were determined by fluorescence-monitored high-performance liquid chromatography (HPLC). A detailed description of these procedures follows.
Determination of deaminase activity. A solution containing 10 mM Tris hydrochloride (pH 8.0), 8 mM MgCl 2 , 30 mM dithiothreitol (DTT), 5 mM GTP, and 2 mg of recombinant GTP cyclohydrolase II per ml was incubated at 37ЊC for 30 min. The reaction was terminated by the addition of 0.5 M EDTA to a final concentration of 25 mM. Aliquots of 40 l were added to a solution (20 l) containing 600 mM potassium phosphate (pH 7.8) and protein. The mixture was incubated at 37ЊC for 30 min. A solution (50 l) containing 1% (vol/vol) diacetyl and 15% (wt/vol) trichloroacetic acid was added, and the mixture was incubated at 95ЊC for 1 h. Fluorescent products were separated by reverse-phase HPLC with a column of Nucleosil RP18 (4 by 250 mm) and an eluent containing 10% (vol/vol) methanol and 0.1% trifluoroacetic acid at a flow rate of 2 ml/min. The effluent was monitored fluorometrically (excitation, 330 nm; emission, 435 nm). The retention volumes of 6,7-dimethyllumazine (compound 8) and 6,7-dimethylpterin (compound 7) were 22.5 and 12.5 ml, respectively.
Determination of reductase activity. A solution containing 10 mM Tris hydrochloride (pH 8.0), 8 mM MgCl 2 , 30 mM DTT, 5 mM GTP, 100 g of recombinant GTP cyclohydrolase II, and 100 g of recombinant RibD protein of E. coli (see below) in a total volume of 50 l was incubated at 37ЊC for 30 min. The solution was passed through a Centricon C30 cartridge (Amicon) to remove protein. The ultrafiltrate was mixed with a solution containing 600 mM potassium phosphate buffer (pH 7.8), 2 M NADPH, 0.25 mM glucose 6-phosphate, and 0.5 U of glucose 6-phosphate dehydrogenase at a ratio of 5:1. Aliquots (60 l) of this solution were mixed with the protein solution (40 l) to be assayed for reductase activity. The mixture was incubated at 37ЊC for 30 min. A solution (50 l) containing 1% (vol/vol) diacetyl and 15% (wt/vol) trichloroacetic acid was added, and the mixture was incubated for 1 h at 37ЊC. 6,7-Dimethyl-8-ribityllumazine 5Ј-phosphate (compound 9) was monitored by reverse-phase HPLC with a column of Nucleosil RP18 (4 by 250 mm) and an eluent containing 7% methanol and 30 mM formic acid. The flow rate was 2 ml/min. The effluent was monitored fluorometrically (excitation, 408 nm; emission, 485 nm). The retention volume of compound 9 was 7.0 ml.
Construction of expression plasmids for the ribD gene of E. coli and the ribG gene of B. subtilis. The ribD gene was amplified by PCR with chromosomal DNA from E. coli RR28 as template, the oligonucleotide RibD1 as forward primer, and the oligonucleotide RibD2 as reverse primer ( Fig. 4 and 5 ). The GTG start codon in the native E. coli sequence was replaced by ATG in the expression construct. The ribG gene of B. subtilis was amplified with the plasmid pRF2 as template and the primers RibG1 and RibG2. Each amplification product served as template in a second PCR with the universal forward primer P2, which is complementary to the ribosome binding site of the expression vector p602/-CAT, and the reverse primer RibD2 (for the E. coli gene) or RibG2 (for the B. subtilis gene). The PCR products were cleaved with EcoRI and BamHI and were ligated into the expression vector p602/-CAT which had been digested with EcoRI and BamHI. The expression plasmids designated p602-RibD and p602-RibG were transformed into E. coli M15(pGB3) cells carrying the pGB3 repressor plasmid for the overexpression of lac repressor protein. Kanamycin (15 g/ml) and ampicillin (150 g/ml) were added for maintenance of both plasmids in the host strain. Clones were analyzed by PCR screening with the universal primer P2 and the selective primer RibD2 or RibG2. Both constructs were monitored by restriction analysis and by DNA sequencing of the 5Ј and the 3Ј ends of the plasmid inserts.
Construction of expression plasmids for N-terminal domains of the RibG protein of B. subtilis. Sections at the 5Ј end of the ribG gene were amplified by PCR with plasmid pRF2 as template and with primers shown in Fig. 5 and Table  2 . The primer G-N1 created an NcoI site at the 5Ј end of the ribG gene. Each of the reverse primers G-DE1 to G-DE5 introduced a BamHI site. Codons for the amino acids A179, K115, V121, V148, and G158 were changed to stop codons by the respective primers. The PCR fragments were ligated into a pBluescript II SK Ϫ vector which had been digested with EcoRV and subsequently tailed with dTTP and Taq DNA polymerase. The plasmids were transformed into E. coli XL1-blue cells and were analyzed by restriction analysis. Clones containing the deaminase domains were then cleaved with NcoI and BamHI. The resulting fragments were purified using the Geneclean II kit and were then ligated into a NcoI-BamHI-digested pNCO113 expression vector, yielding plasmids pNCO-G-DE1 to pNCO-G-DE5, which were transformed into E. coli M15(pREP4).
Construction of an expression plasmid for a C-terminal domain of the RibG protein of B. subtilis. The 3Ј part of the ribG gene was amplified by PCR with plasmid pRF2 as template. The forward primer (G-RED) introduced a BspHI site at the codon for residue M113 ( Fig. 4 ; Table 3 ). The reverse primer was RibG2. The amplificate was ligated into a pBluescript II SK Ϫ vector which had been digested with EcoRV and subsequently tailed with dTTP and Taq DNA polymerase. The resulting plasmid was transformed into E. coli XL1-blue cells. The plasmid was reisolated and was digested with BspHI and BamHI. An 820-bp FIG. 1. Biosynthesis of riboflavin. GTP cyclohydrolase II is specified by ribA in E. coli and B. subtilis and by RIB1 in S. cerevisiae; deaminase is specified by ribD in E. coli, by ribG in B. subtilis, and by RIB2 in S. cerevisiae; reductase is specified by ribD in E. coli, by ribG in B. subtilis, and by RIB7 in S. cerevisiae. 1, GTP; 2, 2,5-diamino-6-ribosylamino-4(3H)-pyrimidinone 5Ј-phosphate; 3, 5-amino-6-ribosylamino-2,4(1H,3H)-pyrimidinedione 5Ј-phosphate; 4, 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5Ј-phosphate; 5, 5-amino-6-ribitylamino-2,4 (1H,3H)-pyrimidinedione 5Ј-phosphate; 6, riboflavin. fragment was isolated from an agarose gel with the Geneclean II kit and was ligated into a NcoI-BamHI-digested pNCO113 expression vector, yielding plasmid pNCO-G-RED.
DNA sequencing. Sequencing was performed by the Sanger dideoxy chain termination method with a model 373A DNA sequencer from Applied Biosystems, Foster City, Calif. E. coli cells for DNA isolation were grown overnight in LB medium containing 150 g of ampicillin and 15 g of kanamycin per ml. DNA was isolated by the modified alkali-sodium dodecyl sulfate method described by Birnboim and Doly (4) with Nucleobond AX-100 columns from Macherey & Nagel, Düren, Germany. Plasmids were sequenced using the oligonucleotides S1 (pNCO), S2 (p602/-CAT), and S3 (Table 3) .
Purification of recombinant RibD protein of E. coli and RibG protein of B. subtilis. The recombinant deaminase-reductase of E. coli and B. subtilis could be purified by the same procedure. Recombinant E. coli strains carrying hyperexpression plasmids with the ribD gene of E. coli or the ribG of B. subtilis were grown in LB medium containing ampicillin (150 mg/l) and kanamycin (15 mg/l). At an optical density at 600 nm of about 0.6 to 0.8, isopropylthiogalactoside was added to a final concentration of 0.5 mM. The suspension was incubated for 5 h with shaking. The cells were harvested by centrifugation (4,500 ϫ g, 15 min, 4ЊC), washed with 154 mM NaCl, and stored at Ϫ20ЊC.
Frozen cell mass (4 g) was thawed in 40 ml of a solution containing 50 mM Tris hydrochloride (pH 8.0), 0.3 mM phenylmethylsulfonyl fluoride, 40 mg of lysozyme, and 40 mg of DNase. The mixture was incubated at 37ЊC for 5 h. The suspension was centrifuged (27,000 ϫ g, 20 min, 4ЊC), and the supernatant was dialyzed overnight against 25 mM Tris hydrochloride (pH 9.0). The solution was placed on a column of QAE cellulose QA92 (10 by 2.5 cm) which had been equilibrated with 25 mM Tris hydrochloride (pH 9.0). The column was developed with a gradient of 25 to 500 mM NaCl containing 25 mM Tris hydrochloride (pH 9.0). Fractions were collected, and ammonium sulfate was added to a final concentration of 1 M. The solution was applied to a column of butyl Sepharose 
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a Amino acid residues of the ribG gene specified by the plasmid.
4 FF which was developed with a linear gradient of 1 to 0 M ammonium sulfate in 50 mM Tris hydrochloride (pH 9.0; total volume, 500 ml). Fractions were combined, and the protein solution was concentrated by ultracentrifugation for 20 h at 160,000 ϫ g and 4ЊC. Aliquots of 1.5 ml containing 10 to 15 mg of protein were passed through a Superdex 200 column (1.6 by 60 cm), which was developed with 100 mM Tris hydrochloride (pH 8.5). Fractions were concentrated by ultrafiltration (Amicon C30) or ultracentrifugation (160,000 ϫ g, 20 h, 4ЊC). Figure 6 shows an alignment of the deduced sequences for the proteins encoded by the ribG gene of B. subtilis and the ribD gene of E. coli located in close proximity to the nusB gene at 442 kb on the E. coli chromosome. The sequences show 39% identity.
RESULTS
Perkins and Pero had noted earlier (19) that the 5Ј end of the B. subtilis gene is similar to deoxycytidylate deaminase of bacteriophage T2 and S. cerevisiae (13, 14) and suggested tentatively that ribG could specify an enzyme catalyzing the deamination of compound 2. Moreover, it was proposed that the ribT gene of the 5Ј end of the rib operon could code for the enzyme catalyzing the reduction of compound 3 (pyrimidine reductase). More recently, we found sequence similarity with the RIB7 gene (3) of S. cerevisiae. The early steps of the riboflavin pathway are somewhat different in eubacteria and in yeasts (Fig. 1) . Circumstantial evidence indicated that the enzyme specified by the RIB7 gene of S. cerevisiae catalyzes the reduction of the ribosyl side chain. We concluded tentatively that a similarity between the yeast gene RIB7 and the bacterial genes ribD and ribG could imply that the bacterial proteins serve both as deaminase and reductase catalyzing the conversion of compound 2 to compound 5 in two reaction steps.
Gene expression. In order to verify these presumptive catalytic activities of the bacterial genes, expression plasmids were constructed for the ribD gene of E. coli and the ribG gene of B. subtilis as described in Materials and Methods. Recombinant E. coli strains harboring plasmids with the entire ribD or ribG gene produce 40-kDa proteins, accounting for about 20% of cellular protein. The cell extracts showed high deaminase as well as reductase activity.
Enzyme studies. The recombinant RibG and RibD proteins of B. subtilis and E. coli were purified to apparent homogeneity by the same experimental procedure involving anion-exchange FIG. 3 . Assay of deaminase and reductase activities. A, GTP cyclohydrolase II; B, deaminase; C, reductase; 2, 2,5-diamino-6-ribosylamino-4(3H)-pyrimidinone 5Ј-phosphate; 3, 5-amino-6-ribosylamino-2,4(1H,3H)-pyrimidinedione 5Ј-phosphate; 5, 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione 5Ј-phosphate; 7, 6,7-dimethylpterin; 8, 6,7-dimethyllumazine; 9, 6,7-dimethyl-8-ribityllumazine 5Ј-phosphate. chromatography on QAE cellulose followed by gel permeation chromatography ( Table 4) . The catalytic properties of purified recombinant proteins are summarized in Table 5 . The kinetic properties of E. coli and B. subtilis proteins are similar. Both enzymes can use NADH as well as NADPH as cosubstrate.
Domain structure. Expression plasmids directing the synthesis of N-terminal or C-terminal parts of the RibG protein of B. subtilis were constructed. Crude cell extracts of recombinant strains expressing at least 147 amino acid residues of the Nterminal part had deaminase activity (specific activity of 2 mol mg Ϫ1 h Ϫ1 in crude cell extract) and no reductase activity ( Table 6 ). The enzyme activity decreased rapidly with time, and the recombinant proteins could not be purified.
Cell extract of a recombinant strain producing a peptide with 248 C-terminal amino acid residues of the RibG protein showed reductase activity (0.5 mol mg Ϫ1 h
Ϫ1
) and no deaminase activity. Again, the protein could not be purified due to the low stability. It follows that the RibG protein of B. subtilis consists of two domains which can fold independently, yielding enzymatically active, monofunctional proteins, albeit of very poor stability.
The E. coli ribD mutants Rib6 and Rib8 (21) could be complemented by the plasmid pNCO-G-RED coding for the reductase domain. The ribD mutants Rib1, Rib2, Rib3, and Rib4 could be complemented only by plasmids directing the synthesis of the entire RibD or RibG protein. None of the ribD mutants studied could be complemented by constructs directing the synthesis of the deaminase domain.
DISCUSSION
Burrows and Brown (6) reported the partial purification of two different enzymes with deaminase and reductase activities, respectively, from cell extract of an E. coli wild strain. Based on gel filtration experiments, the deaminase was assigned an approximate molecular mass of 80 kDa, and the reductase was assigned an approximate molecular mass of 37 kDa. Hypothetically, a reductase of reduced molecular mass could be obtained from the RibD protein by proteolytic processing in vivo. Assuming that the hypothetical protease is present in a relatively low amount, the majority of recombinant protein in the recombinant hyperexpression strain could remain unprocessed.
Perkins et al. (20) had noted that the ribG gene of B. subtilis has a putative internal ribosome binding site followed by an ATG codon specifying methionine 113. A similar motif is also present in the ribD gene of E. coli (putative ribosome binding site followed by ATG codon specifying methionine 127). Thus, it was conceivable that both genes could yield a full-length protein and also a shorter C-terminal segment with reductase activity by differential translation.
The expression of partially deleted ribG genes of B. subtilis 
a See Table 3 for primer sequences. yields proteins with either deaminase or reductase activity, as shown by enzymatic analysis and by complementation patterns observed with different ribD mutants. These data suggest that the RibG protein consists of two domains which can fold independently. More specifically, the N-terminal 147 amino acids are sufficient for deaminase activity, and the C-terminal 248 amino acids are sufficient for reductase activity. However, the stability of the recombinant proteins obtained by partial deletion of the ribG gene is very low. A deletion analysis of the ribD gene of E. coli has not yet been performed. It remains uncertain whether either of the hypotheses mentioned above (proteolytic processing or translational restart) is sufficient to explain the discrepancies between our findings and those of the earlier studies by Burrows and Brown. However, our data show unequivocally that the ribD gene of E. coli can specify a 40-kDa peptide with both catalytic activities under study. The same is true for the ribG gene of B. subtilis.
Recombinant RibT protein failed to catalyze the reduction of compound 3. The metabolic role of the RibT protein remains unknown, but it is unlikely to be involved in the riboflavin biosynthetic pathway.
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